Stocktoria
Erasca, Inc. ERAS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-07-15
Chart by TradingView
3/9
Piotroski F — financial health
-0.65
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$5.0B
P / B15.3×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$140.9M | -$179.6M | -$141.5M | -$247.4M | -$124.9M |
| Net income | -$124.5M | -$161.7M | -$125.0M | -$242.8M | -$122.8M |
| Operating cash flow | -$95.5M | -$109.4M | -$101.2M | -$103.3M | -$79.6M |
| Free cash flow | -$95.6M | -$109.5M | -$103.0M | -$117.8M | -$90.8M |
| Total assets | $396.2M | $502.5M | $395.3M | $514.9M | $501.4M |
| Total liabilities | $71.0M | $79.0M | $78.6M | $103.1M | $44.9M |
| Shareholders' equity | $325.2M | $423.5M | $316.7M | $411.9M | $456.5M |
| Ratios | |||||
| Return on assets | -31.4% | -32.2% | -31.6% | -47.2% | -24.5% |
| Return on equity | -38.3% | -38.2% | -39.5% | -59.0% | -26.9% |
| Current ratio | 10.04 | 9.84 | 12.26 | 9.13 | 16.02 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,398,869 | $22.6M |
| Point72 Asset Management, L.P. | 693,309 | $11.2M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.65 (distress)
- Working capital / assets 0.651
- Retained earnings / assets -2.252
- EBIT / assets -0.356
- Equity / liabilities 4.581
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001761918 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.